Back to results
US 12,729,182 B2Granted
Crystalline forms of N,N-dimethyltryptamine and methods of using the same
AssigneeAtai Therapeutics, Inc.
InventorsMajed Fawaz, Setu Kasera
Life of this patent
Estimating the term…
Abstract
The present disclosure provides crystalline forms of N,N-dimethyltryptamine, Also provided herein are methods of using crystalline forms of N,N-DMT and compositions comprising the same, e.g., in the treatment of mental health diseases and/or disorders.
Claims18
A crystalline Form IV of N,N-dimethyltryptamine, characterized by peaks in an X-ray powder diffraction (XRPD) pattern at 13.6±0.2, 17.8±0.2, and 20.8±0.2° 2θ.
A crystalline Form III of N,N-dimethyltryptamine, characterized by peaks in an X-ray powder diffraction (XRPD) pattern at 7.6±0.2 and 15.2±0.2° 2θ.
Dependencies are inferred from the claim text.